Display options
Cite
Adachi H, Nakae K, Sakamoto S, et al. Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology. J Antibiot (Tokyo). 2017;doi: 10.1038/ja.2017.138.
Adachi, H., Nakae, K., Sakamoto, S., Nosaka, C., Atsumi, S., Shibuya, M., Higashi, N., Nakajima, M., Irimura, T., & Nishimura, Y. (2017). Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology. The Journal of antibiotics, . https://doi.org/10.1038/ja.2017.138
Adachi, Hayamitsu, et al. "Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology." The Journal of antibiotics vol. (2017). doi: https://doi.org/10.1038/ja.2017.138
Adachi H, Nakae K, Sakamoto S, Nosaka C, Atsumi S, Shibuya M, Higashi N, Nakajima M, Irimura T, Nishimura Y. Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology. J Antibiot (Tokyo). 2017 Nov 01; doi: 10.1038/ja.2017.138. Epub 2017 Nov 01. PMID: 29089599.
Copy Download .nbib Format: NLM
Share it on

J Antibiot (Tokyo). 2017 Nov 01; doi: 10.1038/ja.2017.138. Epub 2017 Nov 01.

Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology.

The Journal of antibiotics

Hayamitsu Adachi, Koichi Nakae, Shuichi Sakamoto, Chisato Nosaka, Sonoko Atsumi, Masabumi Shibuya, Nobuaki Higashi, Motowo Nakajima, Tatsuro Irimura, Yoshio Nishimura

Affiliations

  1. Institute of Microbial Chemistry (BIKAKEN), Numazu Branch, Shizuoka, Japan.
  2. Institute of Microbial Chemistry (BIKAKEN), Tokyo, Japan.
  3. Jobu University, Gunma, Japan.
  4. Hoshi University, Tokyo, Japan.
  5. SBI Pharmaceuticals Co., Ltd., Tokyo, Japan.
  6. Juntendo University School of Medicine, Tokyo, Japan.

PMID: 29089599 DOI: 10.1038/ja.2017.138

Abstract

Microbial metabolites have attracted increasing interest as a source of therapeutics and as probes for biological mechanisms. New microbial metabolites and derivatives targeted at inflammation and bone disease therapy have been identified by focusing on prostaglandin release, osteoblast differentiation and immune cell functions. These modulators of inflammatory processes and bone disease contribute to our understanding of biological mechanisms and support identification of the therapeutic potential of drug lead candidates. The present review describes recent advances in the chemistry and analysis of inhibitors of prostaglandin release or other functional molecules of immune cells, as well as inducers of osteoblast differentiation, including biological and pharmacological activities.The Journal of Antibiotics advance online publication, 1 November 2017; doi:10.1038/ja.2017.138.

References

  1. Am J Pathol. 2010 Jan;176(1):146-57 - PubMed
  2. Mol Biol Cell. 2003 Feb;14(2):545-55 - PubMed
  3. Thromb Haemost. 2009 Nov;102(5):823-8 - PubMed
  4. Blood. 2006 May 1;107(9):3609-16 - PubMed
  5. Biochim Biophys Acta. 2012 Jan;1825(1):49-63 - PubMed
  6. Nature. 1984 Jul 19-25;310(5974):241-4 - PubMed
  7. Tanpakushitsu Kakusan Koso. 1993 Aug;38(11):1891-918 - PubMed
  8. Cancer Res. 2002 May 15;62(10 ):2749-52 - PubMed
  9. J Antibiot (Tokyo). 1994 Jan;47(1):101-7 - PubMed
  10. Gene. 2004 Mar 17;328:1-16 - PubMed
  11. J Immunol. 2004 Mar 15;172(6):3830-5 - PubMed
  12. Blood. 2006 Sep 15;108(6):1849-56 - PubMed
  13. Planta Med. 2002 Oct;68(10):875-80 - PubMed
  14. Science. 2000 Sep 1;289(5484):1508-14 - PubMed
  15. Semin Cell Biol. 1995 Jun;6(3):165-73 - PubMed
  16. J Antibiot (Tokyo). 1974 Dec;27(12):963-9 - PubMed
  17. Mol Endocrinol. 2003 Jan;17(1):56-66 - PubMed
  18. J Immunol. 1988 May 15;140(10):3401-5 - PubMed
  19. Curr Opin Gastroenterol. 2010 Nov;26(6):611-7 - PubMed
  20. J Cell Physiol. 2005 Jan;202(1):304-13 - PubMed
  21. Nat Med. 2001 Nov;7(11):1194-201 - PubMed
  22. J Immunol. 2003 Nov 1;171(9):4853-9 - PubMed
  23. Arch Dermatol Res. 2006 Jun;298(1):23-30 - PubMed
  24. J Antibiot (Tokyo). 1970 Aug;23(8):425-7 - PubMed
  25. J Am Chem Soc. 2002 Dec 11;124(49):14520-1 - PubMed
  26. Cell Tissue Res. 2014 May;356(2):381-90 - PubMed
  27. Eur J Immunol. 2014 Apr;44(4):1016-30 - PubMed
  28. Nat Chem Biol. 2006 Jan;2(1):29-30 - PubMed
  29. Oncogene. 2000 Nov 20;19(49):5598-605 - PubMed
  30. Invasion Metastasis. 1992;12(2):112-27 - PubMed
  31. J Clin Invest. 1989 Mar;83(3):752-6 - PubMed
  32. FEBS J. 2013 May;280(10):2307-19 - PubMed
  33. Leuk Res. 1988;12(9):711-7 - PubMed
  34. Immunol Cell Biol. 1998 Feb;76(1):104-13 - PubMed
  35. Cell Immunol. 2014 Jul;290(1):21-9 - PubMed
  36. Bone. 2016 May;86:119-30 - PubMed
  37. PLoS One. 2010 Jul 30;5(7):e11917 - PubMed
  38. PLoS One. 2015 Jun 03;10(6):e0127032 - PubMed
  39. J Clin Invest. 1985 Oct;76(4):1306-13 - PubMed
  40. J Antibiot (Tokyo). 2003 Mar;56(3):209-13 - PubMed
  41. Chem Biol. 2004 Sep;11(9):1229-38 - PubMed
  42. J Antibiot (Tokyo). 1969 Jun;22(6):283-6 - PubMed
  43. Curr Drug Targets. 2011 Dec;12(13):1888-94 - PubMed
  44. Pharmacol Rev. 2006 Dec;58(4):760-72 - PubMed
  45. J Org Chem. 2000 Jan 14;65(1):2-11 - PubMed
  46. J Nat Prod. 2013 Apr 26;76(4):715-9 - PubMed
  47. Am J Pathol. 2000 Jul;157(1):7-14 - PubMed
  48. J Antibiot (Tokyo). 2010 Dec;63(12):703-8 - PubMed
  49. Biochem Biophys Res Commun. 1978 Jul 28;83(2):704-9 - PubMed
  50. Neurosci Lett. 2005 Nov 18;388(3):132-7 - PubMed
  51. FASEB J. 2015 May;29(5):2010-21 - PubMed
  52. J Biol Chem. 1999 Aug 20;274(34):24153-60 - PubMed
  53. Nat Med. 2002 Aug;8(8):841-9 - PubMed
  54. Biochem Biophys Res Commun. 2008 Oct 24;375(3):435-9 - PubMed
  55. Eur J Immunol. 1990 Mar;20(3):493-9 - PubMed
  56. Planta Med. 1998 Apr;64(3):204-7 - PubMed
  57. Ann Rheum Dis. 1980 Jun;39(3):201-6 - PubMed
  58. J Biomol Screen. 2009 Dec;14(10):1251-6 - PubMed
  59. Int Immunopharmacol. 2016 Jun;35:15-21 - PubMed
  60. Science. 1983 May 6;220(4597):611-3 - PubMed
  61. Blood. 2001 Feb 1;97(3):785-91 - PubMed
  62. Biochim Biophys Acta. 1999 Jun 10;1438(3):399-407 - PubMed
  63. Nature. 2000 Sep 14;407(6801):249-57 - PubMed
  64. Nat Med. 2002 Aug;8(8):831-40 - PubMed
  65. Cell Biol Int. 2005 Jul;29(7):537-41 - PubMed
  66. Expert Opin Ther Pat. 2009 Sep;19(9):1193-228 - PubMed
  67. Int J Mol Med. 2011 Dec;28(6):1049-53 - PubMed
  68. J Antibiot (Tokyo). 2003 Mar;56(3):214-8 - PubMed
  69. Biochem Pharmacol. 1995 Jan 18;49(2):127-40 - PubMed
  70. J Nat Prod. 2013 Apr 26;76(4):510-5 - PubMed
  71. Ann N Y Acad Sci. 1988;540:543-5 - PubMed
  72. J Antibiot (Tokyo). 1991 Sep;44(9):949-55 - PubMed
  73. J Cell Physiol. 1987 Jan;130(1):85-92 - PubMed
  74. PLoS One. 2012;7(5):e35602 - PubMed
  75. Annu Rev Pharmacol Toxicol. 2001;41:661-90 - PubMed
  76. Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9349-54 - PubMed
  77. Chem Pharm Bull (Tokyo). 1990 Feb;38(2):432-5 - PubMed
  78. Biochem Biophys Res Commun. 2012 Jun 15;422(4):751-7 - PubMed
  79. Mol Endocrinol. 2007 Sep;21(9):2124-35 - PubMed
  80. J Cell Mol Med. 2007 May-Jun;11(3):427-52 - PubMed
  81. J Nat Prod. 2013 Apr 26;76(4):720-2 - PubMed
  82. Planta Med. 2004 Sep;70(9):803-7 - PubMed
  83. J Antibiot (Tokyo). 1996 Mar;49(3):321-5 - PubMed
  84. Biochem Biophys Res Commun. 2010 Apr 9;394(3):459-63 - PubMed
  85. J Antibiot (Tokyo). 1994 Jul;47(7):840-2 - PubMed
  86. Atherosclerosis. 2014 Jan;232(1):17-24 - PubMed

Publication Types